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Abstract
Background: Coconut oil is commonly used as herbal medicine worldwide. There is limited information regarding
its effects on the developing embryo and infant growth.
Methods: We investigated the effect of virgin coconut oil post-natally and until 6 weeks old in mice (age of
maturity). Females were fed with either standard, virgin olive oil or virgin coconut oil diets 1 month prior to
copulation, during gestation and continued until weaning of pups. Subsequently, groups of pups borne of the
respective diets were continuously fed the same diet as its mother from weaning until 6 weeks old. Profiles of the
standard and coconut oil diets were analysed by gas chromatography flame ionization detector (GCFID).
Results: Analysis of the mean of the total weight gained/ loss over 6 weeks revealed that in the first 3 weeks, pups
whose mothers were fed virgin coconut oil and virgin olive oil have a significantly lower body weight than that of
standard diet pups. At 6 weeks of age, only virgin coconut oil fed pups exhibited significantly lower body weight.
We report that virgin coconut oil modifies the fatty acid profiles of the standard diet by inducing high levels of
medium chain fatty acids with low levels of essential fatty acids. Furthermore, pups borne by females fed with
virgin coconut oil developed spiky fur.
Conclusion: Our study has demonstrated that virgin coconut oil could affect infant growth and appearance via
maternal intake; we suggest the use of virgin coconut oil as herbal medicine to be treated with caution.
Keywords: Coconut oil, Essential fatty acids, GCFID, Body weight, Spiky fur
Background
Plants are considered the most common and valuable
source of herbal medicine [1] and numerous therapeutic
benefits from plants have been derived over centuries
[2–4]. The use of herbal medicine during pregnancy re-
vealed that between 7 and 55% of pregnant females take
some form of herbal medicine [2, 4, 5]. Recent years
have shown that the usage of herbal medicine in child-
bearing women had become widespread for symptoms
such as ease of delivery and pain management as it is as-
sumed that it is safe [4, 6, 7]. There is however, a vari-
ation between cultures and ethnicities in the usage of
herbal medicine [2, 8]. Women of child-bearing age
recognize that chemicals in drugs as a potential danger
but fail to appreciate the inherent dangers of herbal che-
micals [4, 9]. However, several well-documented studies
have found the association of herbal medicine as the
cause of congenital malformations during pregnancy in-
cluding embryo-toxicity [7, 10–12]. Both long term and
short term use of herbal medicines before, during and
after pregnancy causes low birth weight [13, 14], prema-
ture delivery [15], intrauterine growth retardation [16],
decreased foetal survival rate [16] and increased foetal
distress [17]. The effects of natural health products on
foetal development, however, are poorly understood.
The use of virgin olive oil as our control diet was on the
basis of well-documented literature [18, 19] and it is also
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known to confer various health benefits including acting
as an analgesic [20].
Countries within the Southeast Asian region are rich
in coconut oil and other coconut by-products [21–23].
The coconut oil is extracted oil from the meat of the
matured coconut [24]. Coconut oil is widely used during
pregnancy in these countries where published studies on
the use of herbal medicine during pregnancy has shown
that in certain areas about 61% to 63.9% of women of
child-bearing age used coconut oil as herbal medicine
[1, 21, 25]. Coconut oil has been reported to facilitate
delivery and prevent congenital malformations and/ or
birth defects [1, 24].
Despite wanton usage of coconut oil, to our know-
ledge, there is no clear study which indicates and ex-
plains the benefits or danger of coconut oil treatment
during pregnancy. Information concerning the poten-
tial effect of coconut oil on the growth and develop-
ment of infants are lacking and has yet to be
established. Thus, the objective of this study is to use
an animal model to determine the effects of virgin
coconut oil intake after pregnancy, and during the
early weeks of the pups’ growth and development
until age of maturity (6 weeks).
We asked whether dietary intake of virgin coconut oil
fed to female mice prior to copulation, during copula-
tion and during pregnancy could affect the weight of its
progeny, and whether it could subsequently develop ad-
verse effects in the later-life of offsprings with continued
feeding of the virgin coconut oil diet.
Methods
Animal study
Specified pathogen free outbred CD1 mice were used
and maintained in an Animal Biosafety Level 2 (ABSL2)
facility. Three groups (2 cages per group) of CD1 female
mice were placed into different cages for their respective
diet regimes at 6 weeks of age, mice at 6 weeks of age
are mature and ready to be mated [26]. CD1 female mice
were selected from the same litter with similar weight.
Six cages were prepared whereby each cage contained
three females. Two cages were given the virgin coconut
oil diet which was designated as the experimental group.
Control groups were two cages which were fed the
standard diet and virgin olive oil diet, respectively. A
flowchart of the procedure is as shown in Fig. 1.
Diet preparation and feeding
Feeding commenced 1 month before planned mating be-
tween CD1 males and treatment groups’ females. Com-
mercial cold-pressed virgin coconut oil imported from
the Philippines (Brand: Country Farm) and virgin olive
oil imported from the Italy (Brand: Bertolli) were used.
The oil bottles were kept in the dark and stored in a re-
frigerator to avoid oxidation. The mouse pellets were
soaked using a 10% w/w of the oil formula as previously
described [27–29]. The oil-soaked pellets in our study
contained 10% (w/w) fat, which was considered a work-
able compromise between the normal rat diet containing
5% (w/w) fat and the human diet with up to 35% of en-
ergy derived from fat [30, 31]. Information with the
Fig. 1 The study design and flowchart of experimental groups. Comparison between dietary groups. All pups in various experimental groups
were delivered concurrently. For a duration of 1 month, grouped females were fed with standard (STD), virgin olive oil (OO) diet or virgin
coconut oil (CO) diet. Completions of the absorption of the oil by the pellets were indicated by the change in the colour of soaked pellets with
oil. At 3 weeks of age, the “spiky fur” phenotype developed in pups fed with coconut oil. Both control treatment, STD and OO showed no
obvious differences in phenotype under the same growth condition. At the mature age of 6 weeks; the weight of CO pups is ominously reduced
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detailed composition and total energy for each diet is
listed in Table 1. The diets were changed once every
3 days to minimise oxidation and to maintain the nutri-
tional quality of the diet fed by the mice throughout the
experiment. The food intake was measured throughout
the study.
Mice mating
Timed-mating for all the groups was performed and the
presence of the copulation plug the morning after the
mating was taken as evidence of coitus.
Measurements of weight gained/ loss overtime
The respective weight of each pup in the three study
groups were measured daily using an electronic balance
in order to measure the weight of the pups.
Analysis of fatty acid in the diets
Pellets soaked in oils were left overnight to ensure
complete absorption. The profile of the fatty acids of the
standard pellets, virgin coconut oil and virgin olive oil
immersed pellets respectively were analysed by gas chro-
matography flame ionization (GCFID) at the UnipeQ
Food Research and Safety Unit, Universiti Kebangsaan
Malaysia, Malaysia.
Statistical analysis
The percentages of total fatty acids compositions were
presented as the mean ± SEM. Graphs were generated
and the level of weight was compared between groups
using One-Way ANOVA followed by Bonferroni’s post-
hoc test (Sigma plot version 12.0®). This test was used to
compare between experimental groups and correspond-
ing control groups, by analyzing continuous variables
and to detect the differences of the mean values of
weight gained/ loss over time.
Results
Virgin coconut oil causes low body weight during
development
Pups of the three groups were delivered at 21 days after
copulation. 39 pups were delivered from standard diet
group, 27 pups were delivered from virgin olive oil
group and 33 pups were delivered from virgin coconut
oil group (Table 2). There is no significant difference in
the litter size of mice fed the different diets. This indi-
cates that the diets do not affect the fertility of the fe-
male mice.
Figure 2a shows the weight gained/ loss over time
of the developing mice for the first 3 and 6 weeks of
age before weaning/during lactation and maturity.
Pups borne by females were maintained on their
Table 1 Composition and total energy of each diet
aComposition Extra virgin coconut oil
(0.6 ml per serving)
Virgin olive oil
(0.6 ml per serving)
Mouse pellets Barastoc Brand
(Standard diet) (6 g per serving)






Crude protein N/A 0 g 20.0%
Crude fat 0.6 g 0.6 g 5.0%








































Cholesterol 0 mg 0 mg N/A
Crude fiber/ Carbohydrate 0 g 0 g 5.0%
Sugars 0 g N/A N/A
Salt 0 mg 0 mg 0.5%
Copper N/A N/A 7.5%
Selenium N/A N/A 0.1%
Calcium N/A N/A 0.8%






Note: Energy provided based on 6 g consumption rate per day per mouse, acomposition of each diet based on manufacturer label, bFatty acids composition
based on GCFID analysis, cThermochemical / food kilocalories to kilojoules: 1 kcal = 4.184 kJ, N/A data not available
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respective diets. No aversion to the oil-soaked pellets
was seen as the volume of food consumed was simi-
lar, irrespective of diets (Table 3). There is no signifi-
cant difference in mean of consumption rate (g per
day) among diets (P > 0.05) The weight of pups fed
with virgin coconut oil showed significantly low body
weight when compared to corresponding control
groups at 3 weeks of age and 6 weeks of age (P <
0.05) (Figs. 2a, 3a & b). Interestingly, pups of females
fed with virgin olive oil also exhibited significantly
Table 2 Average litter size (mean ± SE) for each treatment
Treatment Litter 1 Litter 2 Litter 3 Mean ± SE
STD 15 10 14 13 ± 1.53
OO 11 8 8 9 ± 1.00
CO 12 9 12 11 ± 1.00
Note: STD standard diet, OO olive oil diet, CO coconut oil diet
Fig. 2 Comparison and phenotype of weight changes of dietary groups. a: We compared the weight between pups of the three groups at 3 and
6 weeks of age. Both OO- and CO- fed pups showed delay in growth and development compared to the STD fed pups at 3 weeks of age. Pups
of control groups were significantly (P < 0.05) (One-way ANOVA) higher in weight over those fed with virgin coconut oil. Although weight of
pups fed with virgin olive oil was significantly (P < 0.05) lower than those fed with STD at 6 weeks of age, pups fed with virgin olive oil had
developed normally at late weaning stage of growth, due to insignificant (P > 0.05) differences in (One way ANOVA) weight gained corresponding to
STD. Mann-Whitney Rank Sum Test shows that pups fed with virgin coconut oil were significantly (P < 0.05) delayed in growth to the virgin olive oil
control and STD at 6 weeks of age. Single asterisk (*) represent significant differences between groups at 3-weeks of age. Double asterisk (**) represent
significant differences between groups at 6-weeks of age. Values represent means, error bars are standard deviation. b: A typical CD1 mouse on normal
diet. c: A typical CD1 mouse on virgin olive oil diet. d: A typical CD1 mouse on virgin coconut oil diet which exhibits the “spiky fur” coat phenotype
and evidently skinnier than other littermates (n = 3 out of a total of 3 litters, N = 33). e & f: A typical mouse on virgin coconut oil diet which exhibits
the “spiky fur” coat phenotype on its dorsal aspect
Table 3 Measurement of food intake (Mean ± SE) for each
treatment
Treatment Consumption rate (g per day)
STD 4.73 ± 0.16
CO 4.78 ± 0.10
OO 5.13 ± 0.13
Note: STD standard diet, OO olive oil diet, CO coconut oil diet
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low body weights compared to the standard diet
group at 3 weeks of age (P < 0.05) (Figs. 2a & 3a).
However, weight of pups fed with olive oil showed
normal weight during maturity (6 weeks) in compari-
son to the standard diet mice (Figs. 2a & 3b); a com-
parison between the two diets proved insignificant
(P > 0.05) (One-way ANOVA).
Virgin coconut oil causes spiky fur phenotype
We observed that all of the 33 delivered pups treated
with coconut oil developed irregularly arranged, odd-
looking fur which we named as “spiky fur” (Fig. 2d, e &
f). A typical phenotypic representation of the coconut
oil diet mice are as shown in Fig. 2e & f. The mice were
in general, healthy despite the unexplained dishevelled
Fig. 3 Fatty acid profile of the diets analysed by GCFID and alteration in the fatty acid profile of standard diet (Brand: Barastoc) when treated
with virgin coconut oil as detected by GCFID. Fatty acids were transformed into fatty acid methyl ester via trans-esterification method. a & b:
Growth curve showing increase in weight over time of which coconut oil diet shows consistent low body weight over time in comparison to
standard diet. a: Measurement taken beginning at the onset of the dietary intervention until 3 weeks of age. b: Increase in weight until 6 weeks
of age and showing data through the end of the experiment. *shows significant decrease in body weight in comparison to standard diet. c: The
chromatogram shows the results of standard diet (STD) fatty acid profile; omega-6 linoleic acid, elaidic acid and palmitic acid appeared to be the
highest in the profile of STD as indicated by blue arrows. d: The chromatogram shows the results of virgin coconut oil diet (CO) fatty acid profile;
caprylic acid, capric acid, lauric acid and myristic acid were pronounced in its increase as indicated by red arrows. Elaidic acid, linoleic acid, alpha
linoleic acid, erucic acid, docosadienoic acid and docosahexaenoic acid were visibly reduced, indicated by blue arrows. Docosahexaenoic acid was
reduced from 2.2% in STD to 0% in virgin coconut oil diet, indicated by blue circled arrow. Capric acid increased from 0% in STD to 5.9% in virgin
coconut oil diet, indicated by red circled arrow. e: Histogram showing representation of fatty acids from c. f: Histogram showing representation of
change in fatty acids after virgin coconut oil treatment. Vast increase in the percentage of caprylic acid, capric acid, lauric acid and myristic acid,
as a result, MCFAs of the total fatty acid profile of STD diet was raised. All data are based on laboratory analysis
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furs which were mostly spiky on the dorsal aspect of the
mice (Fig. 2e & f). Among the 33 pups, three had point-
edly spiky fur and was obviously skinnier than the rest.
A typical pup is as shown in Fig. 2d. The three were
somewhat lethargic and moved less robustly than its lit-
termates although this was not measured. This pheno-
type did not develop in any the other pups fed with
either virgin olive oil or standard diet under the same
condition (Fig. 2b & c).
Virgin coconut oil increases medium chain fatty acid of
the diet
Fatty acid profile of standard and coconut oil diets
were analyzed by GCFID as shown in Fig. 3c & d.
Percentage of medium chain fatty acids (MCFAs)
were highly elevated after standard pellets were
soaked with coconut oil because of the increase of
caprylic acid from 0.1 to 7.2%, capric acid from 0 to
5.9% and lauric acid from 0.5 to 43.5% (Fig. 3d, red
arrows & f). Caprylic acid, capric acid and lauric acid
are categorized under MCFAs [32]. Moreover, myristic
acid was also altered to a high percentage from 1.1 to
13.7% (Fig. 3d & f). On the other hand, certain fatty
acids were altered to a lower percentage such as pal-
mitic acid from 14.8 to 8.5%, elaidic acid from 20 to
7.8%, erucic acid from 4 to 0.1%, docosadienoic acid
from 9.7 to 1% and docosahexaenoic acid (DHA)
from 2.2 to 0% (Fig. 3d, blue arrows & f). Interest-
ingly, essential fatty acids (EFAs) such as linoleic acid
and alpha linoleic acid were also reduced from 21.7
to 6.3% and 2.3% to 0.5%, respectively (Fig. 3d, blue
arrows & f).
Discussion
Coconut oil is known as a natural health product [33, 34].
No published study as yet has indicated the safety of coco-
nut oil in pregnancy and infancy. Coconut oil is known to
be a natural source of Medium Chain Triglycerides
(MCTs) [35]. During digestion, MCTs will be converted to
medium chain fatty acids (MCFAs) which cause weight
loss and high energy expenditure [36]. In brief, fat is the
primary source of energy [37], MCFAs metabolises quickly
and lack the ability to be deposited as adipose tissue. This
is because MCFAs are transported directly in the portal
venous system and therefore bypasses peripheral tissues
such as adipose tissue, therefore decreasing fatty depos-
ition stores and lead to high energy expenditure [35]. Des-
pite the fact that MCTs are known to be associated with
low body weight in infants, it is still being used extensively
as a source of energy for infant formulas and total paren-
teral nutrition [32, 35, 38]. The highly induced MCFAs in
the diet could be the primary cause of the diminished
weight during lactation and adulthood of the virgin coco-
nut oil group, as in previous studies, animals fed with
MCFAs had less weight gained associated with decreased
fat deposition [36]. Caprylic acid, capric acid and lauric
acid are fatty acids belonging to MCFAs [32, 39]. In
our study, we noticed that the level of MCFAs is
highly increased by the elevation in the concentration
of caprylic acid, capric acid and lauric acid in the vir-
gin coconut oil diet (Fig. 3d & f). Although caprylic
acid does not have a direct effect on weight gain/loss;
it does however influence the mechanism of acylation
of ghrelin which modulates appetites and feelings of
satiety [40]. Furthermore, both capric acid and lauric
acid promotes fatty acid oxidation which directly in-
creases satiety and therefore have a direct effect on
weight gain/loss [41]. Besides that, the reduction in
the weight gain observed may be influenced by the
genotype of the animal. The dietary administration of
MCTs may influence mRNA expression of genes cap-
able of modifying the lipogenic ability of the animal;
therefore altering the phenotype of the animal [42].
MCTs are agents of body fat reduction which works
via the peroxisome proliferator activated receptor-γ
by down-regulating adipogenic genes. It is interesting
to note that the effect of MCFAs have an abiding ef-
fect on body weight reduction although the mechan-
ism often involves an increase in fasting cholesterol
as well as triglyceride levels. There is a certain degree
of dispute in this whereby MCFAs have been noted
to reduce fasting lipid levels provided MCFAs are
given in moderate amounts in the form of moderate
fat supply [43]. We are the first to examine the
changes in fatty acids profile of diets altered with the
addition of common cooking oils, and thus the first
to study the association of low body weight in
weaned pups and matured mice of the virgin coconut
oil diet.
Coconut oil had caused a significant decrease in
weight of pups compared to standard and virgin olive oil
fed pups (Fig. 2). Our study examined virgin coconut oil
which is rich in MCTs (Fig. 3), in particular, established
virgin coconut oil feeding on infant development, body
weight and other phenotypes during lactation and until
maturity. Our study provides extra evidence for the use
of MCTs oil (such as coconut oil) as part of a weight-
loss program. In recent studies, it was suggested that
MCTs diet could be useful for controlling body weight
gained fat in healthy adult subjects [44] but we suggest
treating the use of coconut oil during pregnancy and in-
fancy with caution. The MCTs had no toxicological
properties even with long-term feeding diets [44]. Never-
theless, MCTs adversely alters lipid profile by increasing
total plasma cholesterol, higher low density lipoprotein
cholesterol and higher plasma total triglycerol [45].
Other than MCTs, the potential mechanism for the
decrease in growth and development of pups fed with
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coconut oil diet may be due to the deficiency in docosa-
hexaenoic acid (DHA) that is essential for infants’
growth [46, 47]. MCFAs have also been found to secrete
peptide YY (PYY) which causes postprandial satiety sig-
nalling in mammals although this is potentially secreted
in response to long chain triglycerides as well [48].
Since, our study focussed on the fatty acid profile of oil
and their relation to lower body weight, more detailed
studies on the metabolic enzymes and relevant hormone
levels changes in mice due to oil consumption needs to
be done in the future. It is known that vegetables pre-
pared with raw oils help increase the absorption of nu-
trients such as carotenoid [49, 50]. MCTs oil has also
been used to treat impaired absorption of long-chain fats
in patients [51]. MCTs consumption causes slight eleva-
tion in triglyceride level in children with malabsorption
syndromes [52].
Furthermore, this is the first report of a spiky fur
phenotype in mice although previous literature have
shown that in the absence of essential amino acids and
certain proteins, the spiky fur phenotype have been ob-
served in rats [53]. This information tallies with our
GCFID data on the coconut oil itself which shows a
much lowered amount of essential fatty acids in com-
parison to olive oil and the non-oil treated control. We
postulate therefore that in the absence or reduced
amounts of both essential amino acids and essential fatty
acids, the mice suffer in its coat quality.
We have shown evidence that the likelihood of virgin
coconut oil for dietary consumption during and after
pregnancy may cause harmful effects to the developing
pup until maturity of the mice. On the basis of our find-
ings, we stress that coconut oil as herbal medicine for
pregnant women, infants and growing children need to
be studied more intensively.
Conclusion
Experimentally, we have shown in this study that virgin
coconut oil alters the essential fatty acids profile and
lipid profile in standard mouse pellet; thereby inducing
high levels of MCFAs/ MCTs. We observe that this
change then in turn causes low body weight and changes
quality of fur coat of mice which we have coined as the
spiky fur phenotype. Our findings warrant further inves-
tigation and monitoring of coconut oil usage in women
of child-bearing years. Therefore, we report that the use
of coconut oil during pregnancy for prolonged periods
should be assessed with caution until sufficient data and
information becomes available.
Abbreviations
DHA: Docosahexaenoic acid; EFAs: Essential fatty acids; GCFID: Gas
chromatography flame ionization detector; MCFAs: Medium chain fatty acids;
MCTs: Medium chain triglycerides; PYY: Peptide YY
Acknowledgements
We acknowledge the Department of Parasitology, University of Malaya for
the use of laboratory facilities.
Funding
Financial support provided by High Impact Research Grant J-20011-73595
from the University of Malaya and High Impact Research Grant UM-MOHE
E000032 from the Ministry of Higher Education Malaysia (to NMAA), High
Impact Research Grant UM-MOHE E00029 from the Ministry of Higher Education
Malaysia (to AAA); GUP-2011-201 from Universiti Kebangsaan Malaysia (to AA);
Postgraduate Scholarship Scheme and Postgraduate Research Fund PG137-2015A
from the University of Malaya (to RG). The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Availability of data and materials
The datasets used and/or analysed during the current study available from
the corresponding author on reasonable request.
Authors’ contributions
MRS, AA and NMAA conceived and designed the experiments. RG, MRS and
SWMZ performed the experiments. RG, MRS, AA and NMAA analyzed the
data. RG, MRS, AAA and NMAA wrote the paper. All authors read and
approved the final manuscript.
Competing interests




The Institutional Animal Care and Use Committee of University of Malaya
approved our research protocols for the animal studies (IACUC: PAR/20/09/
2011/NMAA-R).
Author details
1Department of Parasitology, Faculty of Medicine, University of Malaya, 50603
Kuala Lumpur, Malaysia. 2Department of Anatomy, Brain Korea 21 Program,
Korea University College of Medicine, Seoul 136-705, Korea. 3School of
Chemical Sciences and Food Technology, Faculty of Science and
Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia.
4Department of Biomedical Science, Faculty of Medicine, University of
Malaya, 50603 Kuala Lumpur, Malaysia.
Received: 16 December 2015 Accepted: 24 January 2017
References
1. Ab Rahman A, Ahmad Z, Naing L, Sulaiman SA, Hamid AM, Daud WN. The
use of herbal medicines during pregnancy and perinatal mortality in
Tumpat District, Kelantan, Malaysia. Southeast Asian J Trop Med Public
Health. 2007;38:1150–7.
2. Dugoua J. Herbal medicines and pregnancy. J Popul Ther Clin Pharmacol.
2010;17(3):e370–8.
3. Ernst E. Herbal medicinal products during pregnancy: are they safe? BJOG-
Int J Obstet Gy. 2002;109:227–35.
4. Tiran D. The use of herbs by pregnant and childbearing women: a risk-
benefit assessment. Complement Ther Nurs Midwifery. 2003;9:176–81.
5. Pinn G, Pallett L. Herbal medicine in pregnancy. Complement Ther Nurs
Midwifery. 2002;8:77–80.
6. Trigt AM, Waardenburg CM, Haaijer-Ruskamp FM, Jong-van den Berg LTW.
Questions about drugs: how do pregnant women solve them? Pharm
World Sci. 1994;16:354–9.
7. Chan L, Chiu P, Lau T. An in vitro study of ginsenoside Rb1 induced
teratogenicity using a whole rat embryo culture model. Hum Reprod. 2003;
18(10):2166–8.
8. Ernst E, White A. The BBC survey of complementary medicine use in the UK.
Complement Ther Med. 2000;8:32–6.
9. Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among
400 Norwegian women. Pharmacoepidemiol Drug Saf. 2004;13:371–80.
Gunasekaran et al. BMC Complementary and Alternative Medicine  (2017) 17:79 Page 7 of 8
10. Noordalilati MN, Sulaiman SA, Sembulingam K, Afifi SAB. Evaluation of the
teratogenicity study of standardized extract of Andrographis paniculata in
rats. Proceedings of the seminar on medicinal and aromatic plants: Current
trends and perspectives. Kuala Lumpur: Forest Research Institute Malaysia;
2004. p. 45.
11. Chin RKH. Ginseng and common pregnancy disorders. Asia Oceania J
Obstet Gynaecol. 1991;17:379–80.
12. Chan K. Some aspects of toxic contaminants in herbal medicines.
Chemosphere. 2003;52:1361–71.
13. Morris G, Mdlalose B. The use of isihlambezo in the upper Tugela region. S
Afr Fam Prac. 1991;10:169–73.
14. Chuang CH, Lai JN, Wang JD, Chang PJ, Chen PC. Use of Coptidis Rhizoma
and foetal growth: a follow up study of 9895 pregnancies.
Pharmacoepidemiol Drug Saf. 2006;15:185–92.
15. Veale D, Havlik I, Katsoulis L, Kaido T, Arangies N, Olive DW, et al. The
pharmacological assessment of herbal oxytocics used in South African
traditional medicine. Biomed Environ. 1998;2:216–22.
16. Islam M, Sulaiman SA, Kapitonova MY, Jamallullail SMS. Effects of an
indigenous contraceptive herbal formulation on gonadotrophs of the
pituitary gland of the rat. Malays J Med Sci. 2007;14:23–7.
17. Mabina M, Pitsoe S, Moodley J. The effect of traditional herbal medicines on
pregnancy outcome. The King Edward VIII Hospital experience. S Afr Med J.
1997;87:1008.
18. St-Onge MP, Lamarche B, Mauger JF, Jones PJH. Consumption of a
functional oil rich in phytosterols and medium-chain triglyceride oil
improves plasma lipid profiles in men. J Nutr. 2003;133:1815–20.
19. Sbragia L, Nassr ACC, Gonçalves FLL, Schmidt AF, Zuliani CC, Garcia PV, et al.
VEGF receptor expression decreases during lung development in congenital
diaphragmatic hernia induced by nitrofen. Braz J Med Biol Res. 2014;47(2):
171–8.
20. Beauchamp GK, Keast RSJ, Morel D, Lin J, Pika J, Han Q, et al.
Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005;
437:45–6.
21. Rahman AA, Sulaiman SA, Ahmad Z, Daud WNW, Hamid AM. Prevalence
and pattern of use of herbal medicines during pregnancy in Tumpat
district, Kelantan. Malays J Med Sci. 2008;15:40–8.
22. Fife B. Coconut cures: preventing and treating common health problems
with coconut. USA: Piccadilly Books, Ltd; 2005.
23. Fife B. Procedures, formulas and recipes. In: Coconut cures: Preventing and
treating common health problems with coconut. USA: Piccadilly Books, Ltd;
2005. p. 184–5.
24. Liau KM, Lee YY, Chen CK, Rasool AHG. An open-label pilot study to assess
the efficacy and safety of virgin coconut oil in reducing visceral adiposity.
ISRN Pharmacol. 2011. doi:10.5402/2011/949686.
25. Kim Sooi L, Lean KS. Herbal medicines: Malaysian women’s knowledge and
practice. Evid Based Complement Alternat Med. 2013. doi:10.1155/2013/
438139.
26. Heifetz Y, Wolfner MF. Mating, seminal fluid components, and sperm cause
changes in vesicle release in the Drosophila female reproductive tract. Proc
Natl Acad Sci U S A. 2004;101:6261.
27. Iritani N, Fukuda E, Kitamura Y. Effect of corn oil feeding on lipid
peroxidation in rats. J Nutr. 1980;110(5):924–30.
28. Al-Amoudi NS, Abu Araki HA. Evaluation of vegetable and fish oils diets for
the amelioration of diabetes side effects. J Diabetes Metab Disord. 2013;
12(1):13.
29. Palit P, Furman BL, Gray AI. Novel weight-reducing activity of Galega
officinalis in mice. J Pharm Pharmacol. 1999;51(11):1313–9.
30. Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of
the efficacy and safety of herbal medicines used in the treatment of
obesity. World J Gastroenterol. 2009;15(25):3073–85.
31. Siemelink M, Verhoef A, Dormans JA, Span PN, Piersma AH. Dietary fatty acid
composition during pregnancy and lactation in the rat programs growth and
glucose metabolism in the offspring. Diabetologia. 2002;45(10):1397–403.
32. Traul K, Driedger A, Ingle D, Nakhasi D. Review of the toxicologic properties
of medium-chain triglycerides. Food Chem Toxicol. 2000;38:79–98.
33. Fife B. Coconut oil and health. Coconut revival: new possibilities for the ‘tree
of life’. Proceedings of the International Coconut Forum in Cairns, Australia.
2006;125:49–56.
34. Fife B. The healing miracles of coconut oil. USA: Piccadilly Books, Ltd; 2002.
35 Clegg ME. Medium-chain triglycerides are advantageous in promoting
weight loss although not beneficial to exercise performance. Int J Food Sci
Nutr. 2010;61:653–79.
36 Noguchi O, Takeuchi H, Kubota F, Tsuji H, Aoyama T. Larger diet-induced
thermogenesis and less body fat accumulation in rats fed medium-chain
triacylglycerols than in those fed long-chain triacylglycerols. J Nutr Sci
Vitaminol (Tokyo). 2002;48(6):524–9.
37 Coggan AR, Raguso CA, Gastaldelli A, Sidossis LS, Yeckel CW. Fat
metabolism during high-intensity exercise in endurance-trained and
untrained men. Metabolism. 2000;49:122–8.
38 St-Onge MP, Bosarge A. Weight-loss diet that includes consumption of
medium chain triacylglycerol oil leads to a greater rate of weight and fat
mass loss than does olive oil. Am J Clin Nutr. 2008;87:621–6.
39 Shahidi F. Functional and nutraceutical lipids. In: Smith J, Charter E, editors.
Functional Food Product Development. UK: John Wiley & Sons Ltd; 2010. p.
101–7.
40 Lemarié F, Beauchamp E, Legrand P, Rioux V. Revisiting the metabolism and
physiological functions of caprylic acid (C8:0) with special focus on ghrelin
octanoylation. Biochimie. 2016;120:40–8.
41 Lemarié F, Beauchamp E, Dayot S, Duby C, Legrand P, Rioux V. Dietary
caprylic acid (C8:0) does not increase plasma acylated ghrelin but decreases
plasma unacylated ghrelin in the rat. Plos One. 2015;10(7), e0133600. doi:10.
1371/journal.pone.0133600.
42 Ferreira L, Lisenko K, Barros B, Zangeronimo M, Pereira L, Sousa R. Influence
of medium-chain triglycerides on consumption and weight gain in rats: a
systematic review. J Anim Physiol Anim Nutr (Berl). 2014;98(1):1–8.
43 Marten B, Pfeuffer M, Schrezenmeir J. Medium-chain triglycerides. Int Dairy J.
2006;16(11):1374–82.
44 Nagao K, Yanagita T. Medium-chain fatty acids: functional lipids for the
prevention and treatment of the metabolic syndrome. Pharmacol Res. 2010;
61:208–12.
45 Tholstrup T, Ehnholm C, Jauhiainen M, Petersen M, Høy CE, Lund P, et al.
Effects of medium-chain fatty acids and oleic acid on blood lipids,
lipoproteins, glucose, insulin, and lipid transfer protein activities. Am J Clin
Nutr. 2004;79:564–9.
46 Al MD, van Houwelingen AC, Hornstra G. Long-chain polyunsaturated fatty
acids, pregnancy, and pregnancy outcome. Am J Clin Nutr. 2000;71(1
Suppl):285s–91.
47 Lee HS, Barraza-Villarreal A, Biessy C, Duarte-Salles T, Sly PD, Ramakrishnan U,
et al. Dietary supplementation with polyunsaturated fatty acid during
pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and
growth of infants. Physiol Genomics. 2014;46(23):851–7.
48 Maas MIM, Hopman WPM, Katan MB, Jansen JBMJ. Release of peptide YY
and inhibition of gastric acid secretion by long-chain and medium-chain
triglycerides but not by sucrose polyester in men. Eur J Clin Investig. 1998;
28:123–30.
49 Conlon LE, King RD, Moran NE, Erdman JW. Coconut oil enhances tomato
carotenoid tissue accumulation compared to safflower oil in the Mongolian
gerbil (Meriones unguiculatus). J Agric Food Chem. 2012;60:8386–94.
50 Goltz SR, Sapper TN, Failla ML, Campbell WW, Ferruzzi MG. Carotenoid
bioavailability from raw vegetables and a moderate amount of oil in human
subjects is greatest when the majority of daily vegetables are consumed at
one meal. Nutr Res. 2013;33:358–66.
51 Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin
Nutr. 1982;36:950–62.
52 Tamir I, Gould S, Fosbrooke AS, Lloyd JK. Serum and adipose tissue lipids in
children receiving medium-chain triglyceride diets. Arch Dis Child. 1969;44:
180–6.
53 Plahar WA, Okezie O, Annan NT. Nutritional quality and storage stability of
extruded weaning foods based on peanut, maize and soybean. Plant Foods
Hum Nutr. 2003;58(3):1–16.
Gunasekaran et al. BMC Complementary and Alternative Medicine  (2017) 17:79 Page 8 of 8
